The following discussion and analysis of our results of operations and financial condition should be read in conjunction with our financial statements and the notes to those financial statements that are included elsewhere in this Annual Report on Form 10-K. Our discussion includes forward-looking statements based upon current expectations that involve risks and uncertainties, such as our plans, objectives, expectations and intentions. Actual results and the timing of events could differ materially from those anticipated in these forward-looking statements as a result of a number of factors. See "Cautionary Note Regarding Forward-Looking Statements" at the beginning of this Annual Report on Form 10-K.

Results of Operation for Years Ended December 31, 2022 and 2021





Revenues


We did not achieve revenues from our current operations for the year ended December 31, 2022 or 2021. We will not achieve revenues unless we are able to market, support and deliver our product and service offerings. There can be no assurances that we will achieve revenues despite our efforts.





Operating Expenses


Our operations for the year ended December 31, 2022 and 2021 are outlined below:





                                                Year Ended December 31,
                                                 2022            2021           Change        %
General and administrative                  $     65,551     $   126,399     $  (60,848 )   (48)%
Professional Fees                           $  2,879,759     $ 2,069,876     $  809,883       39%
Market and regulation costs                 $    198,455     $   170,441     $   28,014       16%
Compensation                                $    671,224     $   612,735     $   58,489       10%
Amortization and depreciation               $    387,302     $   379,887     $    7,415        2%
Research and development                    $     94,645     $   302,808       (208,163 )   (69)%
                                  Total     $  4,296,936     $ 3,662,146     $  634,790       17%




General and administrative


General and administrative expenses consist mainly of costs associated with non-specific costs of running the business. These include but are not limited to the costs of office provision, computer software not associated with research and development, travel, and telecoms.

The decrease in the costs have been mainly due to the decreased costs associated with general advertising spending undertaken in 2021 that was not repeated in 2022.





Professional fees



Professional fees consist of cost in relation to legal, accounting, marketing matters as well as the costs of consultants for our executive and advisory board.

The increase in consultancy costs from 2021 to 2022 is mainly due to the issuance of common stock for consultancy work, and legal fees associated with increased reporting requirements with the SEC pursuant to the Securities Exchange Act of 1934, as amended (the "Exchange Act") and the Company's S-1 filings and application for up-listing to the NASDAQ, as well as of costs regarding the executive board and the recognition of earned stock-based awards under the 2022 incentive plan.





  28


  Table of Contents



Market and regulation expenses

Market and regulation costs are cost incurred specifically in relation to fees and expenses for investor relations, our transfer agent, compliance consultancy and/or market public relations firm.

The increase in costs from 2021 to 2022 is the result of increase in investor relations and market application fee costs as the Company pursues in stated objective of increasing market awareness and progressing with an application for up-listing.





Compensation



Compensation costs are costs incurred by the company in relation to its employees and includes salaries, health insurance, pension costs, training, and any taxes due on employment.

The increase in costs from 2021 to 2022 was due to the increase of costs regarding the recognition of earned stock-based awards under the 2022 incentive plan offset by savings in salaries and general employment costs from 2021 and 2022 as the Company reduced its UK employees and engaged specialist consultants on an "as needed" basis.

Amortization and depreciation

The significant portion of the costs recorded by the Company in regards amortization and depreciation are from the amortization of patents and intellectual property. The majority of patents and intellectual property are held in the UK subsidiary, Bubblr Ltd.

Increase in costs from 2021 to 2022 are due to the additional amortization applied to intellectual property added in Q4 2021 and patents costs of patents granted in 2021 for our patent entitled "Internet-Search Mechanism" patent, being offset by the adverse effects of foreign currency fluctuation on the value of the Great British Pound which has fallen significantly against the United States Dollar in the 12 months to December 31, 2022.





Research and Development


Cost incurred in relation to development of the Company's platform includes mainly costs associated with development staff and specialist software for product development and deployments.

The reduction in costs from 2021 to 2022 resulted from the Company reducing the number of software development contractors as we focused on corporate and financing issues.

Our operating expenses are expected to increase as we further implement our business plan and the added expenses associated with this offering and reporting with the Securities and Exchange Commission.





 Other Income (Expenses)



Our other income for the year ended December 31, 2022 and 2021 are outlined
below:



                                              Year Ended December 31,
                                                2022             2021          Change         %
Interest income                            $       1,553     $    1,554     $       (1 )        - %
Other income                               $     142,212     $   75,263     $   66,949          89%
Gain on settlement of debt                 $          -      $    5,000     $   (5,000 )        - %
Interest expense                           $    (575,777 )   $  (65,316 )   $ (510,461 )       782%
Gain on change in fair value of
warrant derivative liability               $     494,753     $       -      $  494,753         - %

Foreign currency transaction loss $ (191,454 ) $ (47,842 ) $ (143,612 ) 300%


                                   Total   $    (128,713 )   $  (31,341 )   $ (497,372 )       311%




  29


  Table of Contents




Interest Income


The Company earns interest income on its cash reserves and on advances receivable. Any gain on interest from the advances receivable was offset in part by the decrease in interest income from the Company's cash, which decreased during the year.



As of December 31, 2022 and 2021, interest income was received on the following
sources:



                                      Year Ended December 31,
                                       2022             2021         Change       %
Advances receivable               $     1,473       $     1,407     $   66           5%
Cash                              $        80       $       147     $  (67 )      (46)%
                        Total     $     1,553       $     1,554     $   (1 )   -      %




As of December 31, 2022 and 2021, advances receivable consisted of the
following:



                                        December 31,
                                     2022          2021
Advance receivable -G             $  58,606     $ 54,529
Advance receivable -J                21,643       21,643
Repayment received                   (1,231 )         -
Interest due                          1,891        4,079
Assignment of receivables           (71,540 )         -

Effects of currency translation (9,369 ) - Total advances receivable $ - $ 80,251

The advance labelled Advance principal receivable-G carried an interest rate of 3%. The advance principal labelled Advance receivable -J is non-interest bearing. Repayment of $1,231 and $0 was received from G in the nine months to September 30, 2022 and 2021

On December 20, 2022, Advances receivable of $71,540 were assigned to our founder, who now bears all risks and rewards of collection. The assignment corresponded with a reduction in the amount due by the same amount.





 Interest Expense


Interest expense consists mainly of interest the Company has to pay on its borrowings and on vehicle financing held by the Company. In November 2019 the Company entered into a financing arrangement with Alphera Financial Services with which the Company purchased a vehicle. The term of this loan is 5 years and annual interest rate is 6.90%.

The principal amounts outstanding for the Company's borrowings as of December 31, 2022 and December 31, 2021 are as follows:





                                               December 31,
                                           2022           2021            Change         %
Vehicle Financing                       $  22,452     $    35,918     $    (12,957 )   (36)%
Convertible Notes, net                  $      -      $ 2,218,066     $ (2,218,066 )       -
Loans Payable - Related Party           $ 917,461     $   509,339     $    408,122       80%
                                Total   $ 939,913     $ 2,763,323     $ (1,823,410 )   (66)%




  30


  Table of Contents



The decrease in interest expense during the year ended December 31, 2022 as compared to 2021 is due to the Company's converting its convertible notes issued in 2021. On December 15, 2022 noteholders approved a second amendment to the convertible notes for the conversion price to be reduced to $0.50 from $1.15 and immediately elected to voluntarily request for their notes to be converted to common shares at a conversion rate of $0.50c, as a result the company issued 4,706,096 shares of common shares.

Funds raised via the issuance of convertible notes as of December 15, 2022 was $2,287,780 of which $2,112,150 was issued in June 2021, is less an original issuance discount of $104,572 which was amortized over the length of the note to maturity of 18 months and $175,630 issued in November 30, 2021. The Company received a loan from a minority shareholder of $19,709 in February 2022 that bears interest at a rate of 20% per annum and is due for repayment before February 15, 2023. We borrowed a further $501,049 from our founder in Q4 2022. The loan is due for repayment in 3 years and is non-interest bearing. The remaining loan of $374,018 is non-interest bearing and is due for repayment on demand where the maturity date is the earlier of (i) the completion of an offering by Bubblr, Inc., in the amount of no less than $7,500,000 in a public offering, or (ii) May 23, 2024. On September 6, 2023 the loan principal was increased by $60,000 in exchange for Mr. Morris cancelling his Special 2019 Series A Preferred Stock, which has super voting rights. On December 20, 2022, the sum of $71,540 was deducted from the loan principal as a result of the assignment of Advance receivables of $71,540 to our founder.

Gain on change in fair value of warrant derivative liability

The Company analyzed the warrants issued in connection with the Series C Convertible Preferred Stock for derivative accounting consideration under ASC 815, Derivatives and Hedging. ASC 815 requires we assess the fair market value of derivative liability at the end of each reporting period and recognize any change in the fair market value as other income or expense item.

The Company did not issue any warrants in 2021.

The Company analyzed the warrants issued during 2022 in connection with the Series C Convertible Preferred Stock for derivative accounting consideration under ASC 815, Derivatives and Hedging. ASC 815 requires we assess the fair market value of derivative liability at the end of each reporting period and recognize any change in the fair market value as other income or expense item.

For the year ended December 31, 2022, the estimated fair values of the warrant liabilities measured on a recurring basis are as follows:



                                   Year Ended
                                December 31, 2022
Expected term                   2.09 - 2.50 years
Expected average volatility            177 - 220%
Expected dividend yield                     8.33%
Risk-free interest rate              1.50 - 4.73%



The following table summarizes the changes in the warrant liabilities during the period ended December 31, 2022:

Fair Value Measurements Using Significant Unobservable Inputs (Level 3) Warrant liability as of December 31, 2021

                    $           -

Addition of new warrant liabilities                                 721,275
Day-one loss                                                        (28,043 )
Change in fair value of warrant liability                          (494,753 )
Warrant liability as of  December 31, 2022                   $      198,479

The market price of the common stock has decreased from the initial award of warrants in the period ending March 31, 2022. If the warrants were exercised at December 31, 2022 at their respective exercise price determined at issue, the Company would realize a gain due to the difference between the cash received on conversion and the issue cost to the Company of $0.1205 per share, the fair value market price of the common stock at December 31, 2022.





  31


  Table of Contents




Net Loss


We finished the year ended December 31, 2022 with a net loss of $4,425,649 as compared to a loss of $3,693,487 during the year ended December 31, 2021.

Liquidity and Capital Resources





Working Capital


The following table provides selected financial data about our company as of December 31, 2022 and 2021, respectively.





                                 December 31,
                              2022           2021          Change         %
         Current Assets   $   42,417     $  161,184     $ (118,767 )     (74 )%
   Current Liabilities    $  595,856     $  744,820     $ (148,964 )     (20 )%
Working Capital Deficit   $ (553,439 )   $ (583,636 )   $   30,197        (5 )%



We require cash to fund our operating expenses and working capital requirements, including outlays for capital expenditures. As of December 31, 2022, we had $32,533 in the bank, other receivables of $9,884 and advances receivable of $0 as compared to cash of $62,967, other receivables of $17,966, and advances receivable of $80,251 as of December 31, 2021.

During the last two years, and the beginning of this year, we have faced an increasingly challenging liquidity situation that has limited our ability to execute our operating plan. We will need to obtain capital to continue operations. There is no assurance that we will be able to secure such funding on acceptable terms. During the year ended December 31, 2022, we reported a loss from operations of $4,296,936.

As of December 31, 2022, we had assets of cash in the amount of $32,533 and other current assets in the amount of $9,884. As of December 31, 2022, we had current liabilities of $595,856 and a $553,439 working capital deficit. Our accumulated deficit as of December 31, 2022 was $12,875,437.

As of December 31, 2021, we had assets of cash in the amount of $62,967 and other current assets in the amount of $98,217. As of December 31, 2021, we had current liabilities of $744,820 and a $583,363 working capital deficit. Our accumulated deficit as of December 31, 2021 was $8,385,496.

As no revenues are generated from our current operations, we will require additional capital to continue to operate our business, and to further expand our business. Sources of additional capital through various financing transactions or arrangements with third parties may include equity or debt financing, bank loans or revolving credit facilities. We may not be successful in locating suitable financing transactions in the time period required or at all, and we may not obtain the capital we require by other means. Unless we can attract additional investment, our operating as a going concern is in doubt.

We are now obligated to file annual, quarterly and current reports with the SEC pursuant to the Securities Exchange Act of 1934, as amended (the "Exchange Act"). In addition, the Sarbanes-Oxley Act of 2002 ("Sarbanes-Oxley") and the rules subsequently implemented by the SEC and the Public Company Accounting Oversight Board ("PCAOB") have imposed various requirements on public companies, including requiring changes in corporate governance practices. We expect these rules and regulations to increase our legal and financial compliance costs and to make some activities of ours more time-consuming and costly. In order to meet the needs to comply with the requirements of the Exchange Act, we will need investment of capital.

Management has determined that additional capital will be required. There is no assurance that management will be able to raise capital on terms acceptable to us, or at all.

If we are unable to obtain sufficient amounts of additional capital, we may have to cease filing the required reports and cease operations completely. If we obtain additional funds by selling any of our equity securities or by issuing common stock to pay current or future obligations, the percentage ownership of our stockholders will be reduced, stockholders may experience additional dilution, or the equity securities may have rights preferences or privileges senior to the common stock.





  32


  Table of Contents




Cash Flow



                                            Year ended 31 December,
                                             2022             2021           Change
    Cash used in Operating Activities   $ (1,169,701 )   $ (1,577,936 )   $  408,235

Cash used in Investing Activities $ (237,666 ) $ (441,493 ) $ 203,827 Cash provided by Financing Activities $ 1,196,849 $ 1,950,510 $ (753,661 )


                         Cash on Hand   $     32,533     $     62,967     $  (30,434 )




Operating Activities


During the year ended December 31, 2022, we used $1,169,701 in operating activities, compared to $1,577,936 during the year ended December 31, 2021. The reduction of cash used in operating activities was primarily due to an increase in professional, market and regulation fees and compensation, which was offset by non-cash adjustments.





Investing Activities


During the year ended December 31, 2022, we used funds in investing activities of $237,666 to acquire additional intangible assets. During the year ended December 31, 2021, we used funds in investing activities of $441,493 to acquire property and equipment, as well as additional intangible assets. The decrease in funds used in investing activities was primarily because of the reduction in qualifying in-house research and development effort due to the reduction in research and development staff in the year.





Financing Activities


During the year ended December 31, 2022 we raised $1,196,849 as follows: $789,000 through the issuance of Series C Convertible Preferred Stock and associated warrants, $15,000 from loan payable, and $520,758 from loans from related parties. These proceeds were offset through payment of $20,026 dividends due related to our Series C Convertible Preferred Stock, repayment of $9,943

for vehicle financing, $20,000 from loan payable and repayment of $77,940 for loans received from a related party. For the year ended December 31, 2022, we had total cash outflows from financing activities of $127,909, resulting in net cash provided by financing activities of $1,169,849. By comparison, in the year ended December 31, 2021, we raised $2,183,208 from convertible notes offset by repayment of $10,792 for vehicle financing and $303,068 for loans received from a related party. For the year ended December 31, 2021, we had total cash outflows from financing activities of $313,860, resulting in net cash provided by financing activities of $1,950,510.

We also plan to seek additional financing in a private or public equity offering to secure funding for operations. There can be no assurance that we will be successful in raising additional funding. If we are not able to secure additional funding, the implementation of our business plan will be impaired. There can be no assurance that such additional financing will be available to us on acceptable terms or at all.

GHS Investments LLC

On March 4, 2022, we entered a Securities Purchase Agreement (the "GHS Securities Purchase Agreement") with GHS Investments LLC ("GHS"), whereby GHS agreed to purchase, in tranches, up to $700,000 of the Company's Series C Convertible Preferred Stock in exchange for 700 shares of Series C Convertible Preferred Stock. The first tranche, issued promptly upon execution of the GHS Securities Purchase Agreement, was for the purchase of 300 shares of Series C Convertible Preferred Stock for $300,000. The Company issued to GHS commitment shares of 35 shares of Series C Convertible Preferred Stock and a warrant (the "GHS Warrant") to purchase 75% of the number of shares of Common Stock issuable upon conversion of the Series C Convertible Preferred Stock (the "GHS Warrant Shares"). The Company has agreed to register the shares of Common Stock issuable pursuant to the conversion of the Series C Convertible Preferred Stock and the GHS Warrant Shares. GHS delivered gross proceeds of $266,000 to the Company (excluding legal fees and a transaction fee charged by Spartan Capital).

On March 4, 2022, the Company entered into an Equity Financing Agreement and Registration Rights Agreement with GHS. Under the terms of the Equity Financing Agreement, GHS agreed to provide the Company with up to Fifteen Million ($15,000,000) upon effectiveness of a registration statement on Form S-1 filed with the U.S. Securities and Exchange Commission.





  33


  Table of Contents



The Company agreed to issue 587,039 shares of Common Stock to GHS in consideration for entering into the Equity Finance Agreement valued at $234,522.

On April 24, 2022 the Company issued the second tranche of 200 shares of Series C Convertible Preferred Stock and 562,149 warrant shares in accordance with the GHS Securities Purchase Agreement. GHS delivered gross proceeds of $184,000 to the Company (excluding legal fees and a transaction fee charged by Spartan Capital).

On May 25, 2022 the Company issued the third tranche of 100 shares of Series C Convertible Preferred Stock and 281,074 warrant shares in accordance with the GHS Securities Purchase Agreement. GHS delivered gross proceeds of $92,000 to the Company (excluding legal fees and a transaction fee charged by Spartan Capital).

On June 24, 2022 the Company issued the fourth tranche of 100 shares of Series C Convertible Preferred Stock and 281,074 warrant shares in accordance with the Securities Purchase Agreement. GHS delivered gross proceeds of $92,000 to the Company (excluding legal fees and a transaction fee charged by Spartan Capital).

Proactive Capital Group

On March 9, 2022, the Company entered a Securities Purchase Agreement with Proactive Capital Partners LP ("Proactive"), whereby Proactive agreed to purchase 160 shares of Series C Convertible Preferred Stock.

The Company agreed to issue Proactive commitment shares of 8 shares of Series C Convertible Preferred Stock and 472,205 warrant shares (the "Warrant"). Warrant shares represent 75% of the number of shares of common stock issuable upon conversion of the Series C Convertible Preferred Stock (the "Warrant Shares"). The Company agreed to register the shares of common stock issuable pursuant to the conversion of the Series C Convertible Preferred Stock and the Warrant Shares.

On March 9, 2022, the Company issued 168 shares of Series C Convertible Preferred stock to Proactive Capital Partners LP as per the Securities Purchase Agreement. Proactive delivered gross proceeds of $155,000 to the Company (excluded were legal fees).

Stephen Morris (Founder)


The Company has 2 separate loans from our founder, Stephen Morris, with a balance of $899,309 and $428,177 at December 31, 2022 and 2021, respectively.





Loan 1.


On May 23, 2022, the Company entered an amendment to the Loan Agreement between Bubblr Limited and Mr. Morris to change the loan from a demand loan to have maturity date on the earlier of (i) the completion of an offering by Bubblr, Inc., in the amount of no less than $7,500,000 in a public offering, or (ii) two years from the date of the amendment.

In addition, on a date no later than five (5) business days from the completion of bridge financing of no less than $1.5 million USD the Company shall pay to Mr. Morris an amount equal to £115,000 GBP as an instalment payment on the principal of the Loan, and the balance of the principal of the Loan shall be paid at the Maturity Date.

On September 6, 2022, the Company entered into a second amendment (the "Amendment") with Bubblr Limited and Mr. Morris to add $60,000 (£52,088) to the principal of the loan in exchange for Mr. Morris cancelling his Special 2019 Series A Preferred Stock, which has super voting rights.

On December 20, 2022, the Company entered into a third amendment (the "Amendment") with Bubblr Limited and Mr. Morris to reduce the outstanding principal amount of the loan by $71,540 (£59,543) in exchange for the Company assigning advances receivables of $71,540 (£59,543) whereon Mr. Morris is entitled to amounts received pursuant to such receivables and will bear the risk of non-payment with respect to such receivables. After this assignment, the Company will have no right to receive any amounts collected with respect to such receivables and will have no liability for non-payment of the receivables or any costs of collections.





  34


  Table of Contents




Loan 2.


On September 7, 2022, our wholly owned subsidiary, Bubblr Limited, entered into a new loan agreement (the "Loan Agreement") with Mr. Morris for $501,049 (£434,060). The Loan Agreement is unsecured, carries no interest, is non-convertible and is due upon maturity, which is 3 years after the date of the agreement.

The Company received $501,049 and $0 proceeds and made repayments of $0 and $0 during the years ended December 31, 2022 and 2021. The loan principal due was decreased by $11,540 and $66,000 during the year ended December 31, 2022 and 2021, respectively, in regards the sale of the Special 2019 Series A Preferred Stock to Mr. Morris in 2021, and the Company's subsequent repurchase and cancellation of preferred stock and the assignment of debt during 2022.





Minority Shareholder


On February 18, 2022 the Company entered into a Loan Agreement with minority shareholder for $19,709. The loan was for twelve months and bore interest at a rate of 20% per annum. The Principal of $19,709 and interest of $2,396 was repaid February 18, 2023.

Critical Accounting Policies and Significant Judgments and Estimates

This discussion and analysis of our financial condition and results of operations is based on our financial statements, which have been prepared in accordance with generally accepted accounting principles in the United States ("GAAP"). The preparation of these financial statements requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported expenses incurred during the reporting periods. Our estimates are based on our historical experience and on various other factors that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions. While our significant accounting policies are described in more detail in the notes to our financial statements included elsewhere in this prospectus, we believe that the following accounting policies are critical to understanding our historical and future performance, as these policies relate to the more significant areas involving management's judgments and estimates.

We believe our most critical accounting policies and estimates relate to the following:





  •     Foreign Currency Translations
  •     Intangible Assets
  •     Long-lived Assets
  •     Income Taxes



Foreign Currency Translations

The functional currency of the Company's international subsidiaries is generally their local currency of Great British pounds (GBP). Local currency assets and liabilities are translated at the rates of exchange on the balance sheet date, and local currency revenues and expenses are translated at weighted average rates of exchange during the period. Equity accounts are translated at historical rates. The resulting translation adjustments are recorded directly into accumulated other comprehensive income.





Intangible Assets


The cost of intangible assets with determinable useful lives is amortized to reflect the pattern of economic benefits consumed on a straight-line basis over the estimated periods benefited. Patents, technology and other intangibles with contractual terms are generally amortized over their respective legal or contractual lives. When certain events or changes in operating conditions occur, an impairment assessment is performed and lives of intangible assets with determinable lives may be adjusted.





  35


  Table of Contents




Long-Lived Assets


Long-lived assets are evaluated for impairment whenever events or changes in business circumstances indicate that the carrying amount of the assets may not be fully recoverable or that the useful lives of these assets are no longer appropriate. Each impairment test is based on a comparison of the undiscounted future cash flows to the recorded value of the asset. If impairment is indicated, the asset is written down to its estimated fair value.





Income Taxes


The Company accounts for income taxes using the asset and liability method in accordance with ASC 740, "Income Taxes". The asset and liability method provides that deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities and for operating loss and tax credit carry forwards. Deferred tax assets and liabilities are measured using the currently enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company records a valuation allowance to reduce deferred tax assets to the amount that is believed more likely than not to be realized.

Recent Accounting Pronouncements

For discussion of recently issued and adopted accounting pronouncements, please see Note 2 to the audited consolidated financial statements as of and for the years ended December 31, 2022 and 2021 included herein.

Off Balance Sheet Arrangements

As of December 31, 2022, there were no off-balance sheet arrangements.

© Edgar Online, source Glimpses